• Applications & Products
  • Media Formulation
  • About InVitria
  • Contact Us
  • Terms
  • Privacy
  • Sitemap
Performance. Defined.
  • 1-800-916-8311 or Email Us
  • iconMy Account
  • iconView Cart
  • Applications & Products
    • Applications
      • Gene Therapy
      • Cell Therapy
      • T-Cell Immunotherapy
      • Vaccine Production
      • Antibody Production
      • Final Formulation
      • Food Science
    • Product Types
      • Blood-Free Cell Culture Media
      • Cell Culture Components
      • Insulin-Transferrin Supplements
      • Recombinant Albumin
      • Recombinant Transferrin
      • Recombinant Lysozyme
    • Products
      • Cellastim S – Recombinant human albumin
      • Exbumin® – Recombinant human albumin excipient
      • Optibumin – Recombinant human albumin
      • Optiferrin – Recombinant human transferrin
      • Lacromin – Recombinant human holo lactoferrin
      • ITS AF – Blood-free cell culture media supplement
      • ITSE + A – Blood-free cell culture media supplement
      • ITSE Animal-Free® – Blood-free cell culture media supplement
      • Lysobac – Recombinant human lysozyme
      • Leukemia Inhibitory Factor
      • OptiVERO®
      • OptiFRZ®
  • Media Formulation
  • About InVitria
  • News & Blog
  • Contact Us
  • Applications
  • Products
  • Contact Us
  • Home
  • News & Blog

News & Blog

Solving the Vaccine Supply Challenge

SARS-CoV2 and Influenza – Double Threat

High-Performance Production of Viral Vectors for Cell and Gene Therapy Using OptiPEAK HEK293t Complete Media

Recombinant Virus Platforms are Out in Front in the Race to Develop Vaccines Against SARS-CoV-2 and COVID-19 Disease

Controlling Impurities in Cell Culture Media

BioInnovation on Parade: Philly Stands Proud for BIO 2019!

Explore the Latest Developments in T-reg Research and Clinical Application

Exploring the Latest Research and Opportunities in T-reg Therapy

ASGCT 2019: Remarkable Milestones and Achievements in Cell and Gene Therapy

Recombinant Albumin for Stabilization of Live-Attenuated Viral Vaccines

Universal Vaccine Against Seasonal Influenza Steps Closer to Reality with the Results of FluGen Phase 2 Clinical Trial

ECI Conference 2019: The Latest Innovations and Trends in Cell & Gene Therapy

Phacilitate 2019 and World Stem Cell Summit

Join InVitria at ECI 2019

Join InVitria at Phacilitate 2019

Happy Holidays from the InVitria Team!

BIO Europe 2018: From Lab Innovations to Commercial Realities

InVitria Expands Operations to Anschutz Medical Campus in the Denver Metro Area

BIO 2018: The Emergence of Gene & Cell Therapy

InVitria at the American Association of Immunologists 2018 Conference

InVitria’s Top Insights from ISCT 2018 – Montreal

3 Takeaways from the World Vaccine Congress 2018

Quick Search Links

Application:

Antibody Production

Cell Therapy

Final Formulation

Food Science

Gene Therapy

T-Cell Immunotherapy

Vaccine Production

Product Category:

Cell Culture Supplements

Albumin

Cell Culture Media

Lactoferrin

LIF

Lysozyme

Single Components

Transferrin

Product:

Cellastim S® – Recombinant human albumin

Exbumin® – Recombinant human albumin excipient

ITS AF™ – Blood-free cell culture media supplement

ITSE + A™ – Blood-free cell culture media supplement

ITSE Animal-Free® – Blood-free cell culture media supplement

Lacromin® – Recombinant human holo-lactoferrin

Leukemia Inhibitory Factor

Lysobac® – Recombinant human lysozyme

Optibumin® – Recombinant human albumin

Optiferrin® – Recombinant human transferrin

OptiFRZ® – DMSO-Free Cryopreservation Medium

OptiVERO®

Document Type:

Application Notes

Blog

Interviews

Journal Articles (DOI Links)

News

Posters

Product Brochures

Product Specifications

SDS

Use Guidelines

Webinar

White Papers

Cell Line:

B Lymphocyte

CHO

ESC

HEK293

Hematopoetic Stem Cells

Hybridoma

iPSC

Mesenchymal Stem Cells

Natural Killer Cells

Neural Stem Cells

T Lymphocyte

VERO

  • 2718 Industrial Drive • Junction City, KS 66441
  • 800-916-8311
  • © 2023 InVitria

    • Terms
    • Privacy
    • Sitemap